Atopic Dermatitis Treatment Market, By Product (Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others), By Route of Administration (Oral, Topical, Injectable), By End-Users (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI514823 | Publish Date: March 2024 | No. of Pages: 170

Atopic Dermatitis Treatment Market Overview

Atopic Dermatitis Treatment Market was valued at US$ 6 Billion in 2024 and is projected to grow at a CAGR of 5.30% to reach US$ 10 Billion by 2034.

[PDF] Atopic Dermatitis is also called as eczema, a chronic disease that causes redness, inflammation and irritation of skin. Emollients moisturizer are common treatment for atopic dermatitis that are used every day by an infected individual. Various product such as Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others are used in treatment of Atopic Dermatitis.

Atopic Dermatitis Treatment Market Dynamics

Growing Prevalence of Eczema to fuel market growth

Growing prevalence of eczema or atopic dermatitis have become major contribution in target market growth. Environmental exposure, genetics and changing lifestyle factors have contributed in development & progression of eczema. For instance, according to National Eczema Association, around 31.6 million Americans area affected by an eczema an incredibly inflammatory skin condition which begins in first year of life.

Further, in 2021, according to CDC (Centers for Disease Control and Prevention), in United States, the percentage of adults diagnosed with eczema varied by age, sex, race and Hispanic origin. The percentage of eczema was higher in woman about 8.9% as compared to men about 5.7%.

Restrains:

However, expensive treatment of eczema has hampered the demand for Atopic Dermatitis Treatment Market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Atopic Dermatitis Treatment Market Segmentation

Atopic Dermatitis Treatment Market Segmentation:

Atopic Dermatitis Treatment Market is segmented based on Product, Route of Administration, End-Users and Region.

Product Insight

On the basis of Product, Atopic Dermatitis Treatment Market is segmented into Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others.

Route of Administration Insight

On the basis of Route of Administration, Atopic Dermatitis Treatment Market is segmented into Oral, Topical, Injectable.

End-Users Insights

On the basis of End-Users, Atopic Dermatitis Treatment Market is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others.

Atopic Dermatitis Treatment Market Regional Insights:

On region the Atopic Dermatitis Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of eczema, continuous research & development activities and well established healthcare infrastructure.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to growing population, rising incidence of atopic dermatitis and growing awareness among consumers for better treatment.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Recent Development:

             The New Launched Product News,

  • In May 2023, Eli Lilly uneviled new data from its atopic dermatitis new therapy Phase III trials. The new therapy trial shows about 58% to 73% of patients who received lebrikizumab has experienced cleared face dermatitis in 16 weeks after medication.
  • In January 2022, ‘CIBINQO’ (abrocitinib) an oral treatment developed by Pfizer Inc., for adults with moderate-to-severe atopic dermatitis condition has been approved by U.S. FDA (Food and Drug Administration). The new launched approved drug is recommended at doses of 100 mg and 200 mg.

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Product - Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others

By Route of Administration - Oral, Topical, Injectable

By End-Users - Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034

Atopic Dermatitis Treatment Market Key Players

The key players operating the Atopic Dermatitis Treatment Market includes, Novartis, Sanofi SA, Bayer AG, Galderma SA, Bristol-Myers Squibb, Allergan Plc., Astellas Pharma Inc., Regeneron Pharmaceuticals, Anacor Pharmaceuticals, Meda Pharmaceuticals and Others.

Atopic Dermatitis Treatment Market Company Profile

  • Novartis
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sanofi SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Galderma SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Allergan Plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Regeneron Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Anacor Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Meda Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

Atopic Dermatitis Treatment Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Route of Administration
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Product, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Calcineurin Inhibitors
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Corticosteroids
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Biologic Therapy
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Immunosuppressants
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Market Segmentation, By Route of Administration, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Topical
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Injectable
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Market Segmentation, By End-Users, Forecast Period up to 10 Years, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Segment Trends
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

 

  1. Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis

FAQs

The Atopic Dermatitis Treatment Market is segmented into Product, Route of Administration, End-Users and Region.

Atopic Dermatitis Treatment Market is driven by factors like growing prevalence of eczema.

By region, the Atopic Dermatitis Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the Atopic Dermatitis Treatment Market includes, Novartis, Sanofi SA, Bayer AG, Galderma SA, Bristol-Myers Squibb, Allergan Plc., Astellas Pharma Inc., Regeneron Pharmaceuticals, Anacor Pharmaceuticals, Meda Pharmaceuticals and Others.

Atopic Dermatitis Treatment Market was valued at US$ 6 Billion in 2024 and is projected to grow at a CAGR of 5.30% to reach US$ 10 Billion by 2034.